Structure-Based Drug Design and Target Validation 2014 | New Targets for Drug Discovery - a podcast by Cambridge Healthtech Podcasts

CHI recently spoke with Dr. Chas Bountra, Head of the Structural Genomics Consortium (SGC), and Professor of Translational Medicine and an Associate Head of Medical Sciences at the University of Oxford. In this podcast, Dr. Bountra discusses how the SGC is impacting drug discovery and their work on developing novel probes, specifically for epigenetic targets. Dr. Bountra also gives a sneak peek into his keynote lecture joining the Structure-Based Drug Design and Chemical Biology for Target Validation meetings, May 22 in Boston.

Further episodes of CHI Podcasts

Further podcasts by Cambridge Healthtech Podcasts

Website of Cambridge Healthtech Podcasts